Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - ANGIOTECH PHARMACEUTICALS INC | d414313d8k.htm |
| EX-99.3 - PRESS RELEASE, DATED SEPTEMBER 18, 2012 - ANGIOTECH PHARMACEUTICALS INC | d414313dex993.htm |
| EX-99.1 - NOTICE OF OPTIONAL PARTIAL REDEMPTION DATED SEPTEMBER 17, 2012 - ANGIOTECH PHARMACEUTICALS INC | d414313dex991.htm |
Exhibit 99.2
NOTICE OF FULL REDEMPTION
Senior Floating Rate Notes due 2013 of
Angiotech Pharmaceuticals, Inc.
CUSIP No. 034918AF9*
NOTICE IS HEREBY GIVEN, pursuant to Section 3.03 of that certain Indenture dated as of December 11, 2006, by and among Angiotech Pharmaceuticals Inc., a corporation organized under the laws of British Columbia (the “Company”), as issuer, certain subsidiaries of the Company as guarantors referred to therein and Deutsche Bank National Trust Company, as successor to Wells Fargo Bank, N.A., as trustee (the “Trustee”), as supplemented by that certain Supplemental Indenture, dated as of May 12, 2011, among the Company, the guarantors referred to therein, and the Trustee (the indenture, as supplemented, referred to as the “Indenture”), pertaining to the Company’s Senior Floating Rate Notes due 2013 (the “Notes”), that all outstanding Notes, totaling $22,000 in aggregate principal amount, will be redeemed on October 17, 2012 (the “Redemption Date”) at a redemption price equal to the principal amount called together with accrued interest thereon to the Redemption Date.
The terms of the redemption shall be as follows:
a) The Notes are being redeemed pursuant to Paragraph 5 of the Notes and Section 3.7(c) of the Indenture.
b) Interest on the Notes will cease to accrue on and after the Redemption Date, unless the Company defaults in making the redemption payment.
Payment of the redemption price of these FAST Book-entry Notes shall be made to the registered holder thereof, Cede & Co., without presentation. The following is for information only:
| BY MAIL OR OVERNIGHT COURIER | BY HAND | |||
| DB Services Americas, Inc. | DB Services Americas, Inc. | |||
| MS JCK01-0218 | Security Holder Relations | |||
| 5022 Gate Parkway, Suite 200 | 5022 Gate Parkway, Suite 200 | |||
| Jacksonville, FL 32256 | Jacksonville, FL 32256 | |||
| Attn: Security Holder Relations | ||||
| * | The Trustee is not responsible for the selection or use of the CUSIP number, and no representation is made as to the correctness or accuracy of the CUSIP number set forth above or printed on the Notes. The CUSIP number set forth above is included solely for the convenience of the holders of Notes. |
ANGIOTECH PHARMACEUTICALS, INC.,
Company
Date: as of September 17, 2012